Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China flag China · Delayed Price · Currency is CNY
73.07
-0.12 (-0.16%)
May 6, 2026, 3:00 PM CST

SHA:688336 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
282.57193.27459.49933.261,0911,614
Short-Term Investments
-4,488863.59344.19--
Trading Asset Securities
1,1921,074910.54603.871,486752.05
Cash & Short-Term Investments
1,4755,7552,2341,8812,5772,366
Cash Growth
-14.58%157.63%18.73%-27.00%8.93%-14.31%
Accounts Receivable
309.8153.84147.14133.24149.35256.97
Other Receivables
0.110.160.030.20.290.53
Receivables
309.91154147.17133.44149.65257.5
Inventory
279.63260.55229.6194.96227210.14
Other Current Assets
4,02860.2149.6440.0932.5438.09
Total Current Assets
6,0926,2292,6602,2502,9862,872
Property, Plant & Equipment
1,5341,5341,5391,5621,4261,371
Long-Term Investments
98.02442.731,1401,020109.4122.37
Goodwill
0.640.640.640.640.640.64
Other Intangible Assets
317.2208.75223.96240.16195.73196.55
Long-Term Deferred Tax Assets
127.83125.98129.62145.74173.43155.31
Long-Term Deferred Charges
239.65341.94228.5444.44114.0297.67
Other Long-Term Assets
538.5974.3543.6842.1692.7673.59
Total Assets
8,9488,9575,9655,3055,0984,889
Accounts Payable
40.734.9634.9621.9315.9116.27
Accrued Expenses
39.87172.13174.93181.256.18127.71
Short-Term Debt
--50.0250.03150.1-
Current Income Taxes Payable
10.92141.29-1.31.20.21
Current Unearned Revenue
34.1262.120.216.7719.553.25
Other Current Liabilities
151.4436.5436.836.91132.1568.01
Total Current Liabilities
277.05447.02316.91308.14375.09215.45
Long-Term Unearned Revenue
90.9795.6111.24118.33123.79134.28
Total Liabilities
368.01542.62428.15426.47498.88349.73
Common Stock
618.09618.09616.79616.79616.79616.21
Additional Paid-In Capital
2,3962,3862,3102,3032,3092,301
Retained Earnings
5,6405,4622,6391,9851,6911,641
Comprehensive Income & Other
-34.29-13.582.44-8.71-10.67-17.33
Total Common Equity
8,6208,4535,5684,8964,6064,542
Minority Interest
-39.77-38.21-30.76-17.58-6.32-2.46
Shareholders' Equity
8,5808,4155,5374,8794,6004,539
Total Liabilities & Equity
8,9488,9575,9655,3055,0984,889
Total Debt
--50.0250.03150.1-
Net Cash (Debt)
1,4755,7552,1841,8312,4272,366
Net Cash Growth
-12.03%163.53%19.24%-24.55%2.59%-14.31%
Net Cash Per Share
2.379.293.532.983.943.93
Filing Date Shares Outstanding
614.2618.09616.79616.79616.79616.21
Total Common Shares Outstanding
614.2618.09616.79616.79616.79616.21
Working Capital
5,8155,7822,3431,9422,6112,656
Book Value Per Share
14.0313.689.037.947.477.37
Tangible Book Value
8,3028,2445,3434,6554,4094,344
Tangible Book Value Per Share
13.5213.348.667.557.157.05
Buildings
-818.98626.77626.77531.48531.48
Machinery
-1,3331,2201,1961,0431,035
Construction In Progress
-544.11749.65687.81717.11572.47
Source: S&P Global Market Intelligence. Standard template. Financial Sources.